rs3768235

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003921.5(BCL10):​c.638G>A​(p.Gly213Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0591 in 1,613,906 control chromosomes in the GnomAD database, including 3,401 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 250 hom., cov: 33)
Exomes 𝑓: 0.060 ( 3151 hom. )

Consequence

BCL10
NM_003921.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.257

Publications

32 publications found
Variant links:
Genes affected
BCL10 (HGNC:989): (BCL10 immune signaling adaptor) This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BCL10 Gene-Disease associations (from GenCC):
  • immunodeficiency 37
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011563003).
BP6
Variant 1-85267691-C-T is Benign according to our data. Variant chr1-85267691-C-T is described in ClinVar as Benign. ClinVar VariationId is 402410.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.144 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCL10NM_003921.5 linkc.638G>A p.Gly213Glu missense_variant Exon 3 of 3 ENST00000648566.1 NP_003912.1 O95999

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCL10ENST00000648566.1 linkc.638G>A p.Gly213Glu missense_variant Exon 3 of 3 NM_003921.5 ENSP00000498104.1 O95999
BCL10ENST00000620248.3 linkc.605G>A p.Gly202Glu missense_variant Exon 3 of 3 5 ENSP00000480561.2 A0A087WWW9
BCL10ENST00000650582.1 linkn.*38G>A downstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0473
AC:
7199
AN:
152162
Hom.:
251
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0129
Gnomad AMI
AF:
0.102
Gnomad AMR
AF:
0.0606
Gnomad ASJ
AF:
0.0254
Gnomad EAS
AF:
0.154
Gnomad SAS
AF:
0.0899
Gnomad FIN
AF:
0.0463
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0550
Gnomad OTH
AF:
0.0411
GnomAD2 exomes
AF:
0.0651
AC:
16344
AN:
251142
AF XY:
0.0660
show subpopulations
Gnomad AFR exome
AF:
0.0102
Gnomad AMR exome
AF:
0.0799
Gnomad ASJ exome
AF:
0.0254
Gnomad EAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.0461
Gnomad NFE exome
AF:
0.0543
Gnomad OTH exome
AF:
0.0586
GnomAD4 exome
AF:
0.0603
AC:
88113
AN:
1461626
Hom.:
3151
Cov.:
31
AF XY:
0.0610
AC XY:
44361
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.00989
AC:
331
AN:
33466
American (AMR)
AF:
0.0751
AC:
3357
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
671
AN:
26126
East Asian (EAS)
AF:
0.157
AC:
6229
AN:
39684
South Asian (SAS)
AF:
0.0888
AC:
7660
AN:
86218
European-Finnish (FIN)
AF:
0.0475
AC:
2538
AN:
53414
Middle Eastern (MID)
AF:
0.0609
AC:
351
AN:
5762
European-Non Finnish (NFE)
AF:
0.0569
AC:
63221
AN:
1111892
Other (OTH)
AF:
0.0622
AC:
3755
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
4411
8822
13232
17643
22054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2474
4948
7422
9896
12370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0473
AC:
7199
AN:
152280
Hom.:
250
Cov.:
33
AF XY:
0.0474
AC XY:
3530
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0129
AC:
535
AN:
41564
American (AMR)
AF:
0.0608
AC:
930
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0254
AC:
88
AN:
3470
East Asian (EAS)
AF:
0.153
AC:
792
AN:
5182
South Asian (SAS)
AF:
0.0896
AC:
432
AN:
4824
European-Finnish (FIN)
AF:
0.0463
AC:
490
AN:
10592
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0550
AC:
3744
AN:
68034
Other (OTH)
AF:
0.0421
AC:
89
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
349
698
1047
1396
1745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0504
Hom.:
109
Bravo
AF:
0.0466
TwinsUK
AF:
0.0558
AC:
207
ALSPAC
AF:
0.0651
AC:
251
ESP6500AA
AF:
0.0132
AC:
58
ESP6500EA
AF:
0.0566
AC:
487
ExAC
AF:
0.0639
AC:
7761
Asia WGS
AF:
0.141
AC:
488
AN:
3478
EpiCase
AF:
0.0523
EpiControl
AF:
0.0519

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Immunodeficiency 37 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T;T;.
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.64
.;T;T
MetaRNN
Benign
0.0012
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-1.0
N;N;.
PhyloP100
0.26
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.2
.;N;.
REVEL
Benign
0.057
Sift
Benign
0.37
.;T;.
Sift4G
Benign
0.70
.;T;.
Polyphen
0.0
B;B;.
Vest4
0.058
MPC
1.0
ClinPred
0.0061
T
GERP RS
-0.91
Varity_R
0.11
gMVP
0.35
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3768235; hg19: chr1-85733374; COSMIC: COSV65353501; COSMIC: COSV65353501; API